Tuesday, May 5, 2015
- 5:30pm-6:30pm
-
NFAT Regulated Cytokine Gene Expression for Immune Monitoring in Kidney Transplant Recipients
Poster Session D: Kidney Immunosuppression: Drug Minimization • Exhibit Hall E
- 5:30pm-6:30pm
-
NK Cells of Kidney Transplant Recipients Show a Reduced Capacity to Produce Cytokines But Retain Their Cytotoxic Capacity
Poster Session D: Innate Immunity in Transplantation • Exhibit Hall E
- 5:30pm-6:30pm
-
No Tumor Recurrence After Renal Cell Carcinoma Resected Kidney Transplantation – 5 Year Follow Up
Poster Session D: Diabetes/Metabolic/Bone/Malignancy/Pregnancy • Exhibit Hall E
- 5:30pm-6:30pm
-
Non-Invasive Immune Monitoring Assay in Transplant Recipients
Poster Session D: Innate Immunity in Transplantation • Exhibit Hall E
- 5:30pm-6:30pm
-
Noninvasive Diagnostic and Predictive Value in Renal Transplant Recipients by Measurement of Urine BCA-1
Poster Session D: Late Breaking • Exhibit Hall E
- 5:30pm-6:30pm
-
Once Daily Dosing Is as Effective as Twice Daily Dosing of Immediate Release Tacrolimus
Poster Session D: Kidney Immunosuppression: Drug Minimization • Exhibit Hall E
- 5:30pm-6:30pm
-
Once-a-Day Administration of CNIs, mTOR and MMF Is Safe in De Novo Renal Transplant Recipients: 1-Year Results of a Pilot Study
Poster Session D: Kidney Immunosuppression: Drug Minimization • Exhibit Hall E
- 5:30pm-6:30pm
-
Outcome of Adult Kidney Transplant Candidates With Previous Malignancy: Analysis of 14-Year Waiting List Data in the United States
Poster Session D: PTLD/Malignancies: All Topics • Exhibit Hall E
- 5:30pm-6:30pm
-
Outcomes of Hispanic Kidney Transplant Recipients Under a Cyclosporine Versus Tacrolimus Based Immunosuppression Regimen
Poster Session D: Kidney Immunosuppression: Drug Minimization • Exhibit Hall E
- 5:30pm-6:30pm
-
Outcomes of Kidney Transplant Recipients Minimally Immunosuppressed: A Cohort Study Analysis
Poster Session D: Kidney Immunosuppression: Drug Minimization • Exhibit Hall E
- «Previous Page
- 1
- …
- 34
- 35
- 36
- 37
- 38
- …
- 47
- Next Page»